Kwon Ok-Seon, Na Hyeon-Jin, Ahn Jiwon, Chung Kyung-Sook
Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea.
Stem Cell Convergence Research Center, Korea Research Institute of Bioscience and Biotechnology (KRIBB), 125 Gwahak-ro, Yuseong-gu, Daejeon 34141, Republic of Korea; Department of Functional Genomics, Korea University of Science & Technology (UST), 217 Gajungro, Yuseon-gu, Daejeon 34113, Republic of Korea.
Stem Cell Res. 2022 Dec;65:102950. doi: 10.1016/j.scr.2022.102950. Epub 2022 Oct 19.
Given the advantage of being able to be extracted by a minimally invasive method, blood is regarded as a suitable cell source for reprogramming to establish induced pluripotent stem cells (iPSCs). Therefore, iPSCs established from patient derived peripheral blood mononuclear cells (PBMCs) is widely used to develop disease modeling to elucidate disease development. Here, PBMCs from a healthy man were reprogrammed into iPSCs using the Sendai virus. The established iPSC line, KRIBBi006-A, exhibit pluripotency marker and can differentiate into the three germ layers in vitro with normal karyotype. This iPSC line is a valuable resource as a control line for stem cell research of disease models and drug screening.
鉴于血液能够通过微创方法提取的优势,它被视为一种适合用于重编程以建立诱导多能干细胞(iPSC)的细胞来源。因此,由患者外周血单个核细胞(PBMC)建立的iPSC被广泛用于开发疾病模型以阐明疾病发展过程。在此,使用仙台病毒将一名健康男性的PBMC重编程为iPSC。所建立的iPSC系KRIBBi006-A表现出多能性标志物,并且在体外具有正常核型的情况下能够分化为三个胚层。该iPSC系作为疾病模型干细胞研究和药物筛选的对照系是一种有价值的资源。